We further interrogated the underlying mechanism and identified the contribution of YAP-RhoA-myosin II pathway in melanoma negative durotaxis regulation; and for the lack of acral melanoma cell line, whether acral melanoma invasion through negative durotaxis should be further investigated. The gene discussed is YAP1; the disease is acral lentiginous melanoma.